Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Foreign Growth
  • Asset Class: Equity
  • Geographic Focus: International

American Century NT International Growth Fund

+ Add to Watchlist

ACLNX:US

11.83 USD 0.03 0.25%

As of 09:29:30 ET on 05/21/2015.

Snapshot for American Century NT International Growth Fund (ACLNX)

Year To Date: +10.56% 3-Month: +5.25% 3-Year: +15.52% 52-Week Range: 10.21 - 11.83
1-Month: +3.23% 1-Year: +5.57% 5-Year: +11.82% Beta vs MXEA: 1.00

Mutual Fund Chart for ACLNX

No chart data available.
  • ACLNX:US 11.83
  • 1M
  • 1Y
Interactive ACLNX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ACLNX

American Century NT Internatioal Growth Fund is an open-end fund incorporated in the USA. The Fund's objective is capital growth. The Fund invests in securities of companies located in at least three developed countries world-wide (excluding the United States).

Inception Date: 05-12-2006 Telephone: 1-816-531-5575
Managers: RAJESH A GANDHI
Web Site: www.americancentury.com

Fundamentals for ACLNX

NAV (on 2015-05-21) 11.83
Assets (M) (on 2015-04-30) 803.26
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for ACLNX

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-12-16) 0.05
Dividend Yield (ttm) 3.81

Fees & Expenses for ACLNX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.98
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 0.98

Top Fund Holdings for ACLNX

Filing Date: 03/31/2015
Name Position Value % of Total
Novartis AG 207,076 20,477,571 2.705%
Roche Holding AG 66,444 18,321,448 2.420%
Nestle SA 202,230 15,268,250 2.017%
Intesa Sanpaolo SpA 4,221,820 14,326,550 1.893%
Keyence Corp 25,900 14,146,819 1.869%
Reckitt Benckiser Group PLC 157,080 13,462,408 1.779%
Bayer AG 86,170 12,947,496 1.711%
Adecco SA 154,814 12,896,918 1.704%
Accor SA 243,910 12,739,436 1.683%
Shire PLC 151,090 12,014,729 1.587%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil